APA (7th ed.) Citation

YE, A., O, K., D, I., TK, G., U, Ö., T, B., . . . N, T. (2025). Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment. Cancers, 17(7), . https://doi.org/10.3390/cancers17071076

Chicago Style (17th ed.) Citation

YE, Altıntaş, Kınıkoğlu O, Işık D, Güneş TK, Özkerim U, Basoglu T, Sürmeli H, Odabaş H, and Turan N. "Very Favorable Vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment." Cancers 17, no. 7 (2025). https://doi.org/10.3390/cancers17071076.

MLA (9th ed.) Citation

YE, Altıntaş, et al. "Very Favorable Vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment." Cancers, vol. 17, no. 7, 2025, https://doi.org/10.3390/cancers17071076.